Director – E. Francis Cook, ScD, is a Professor of Epidemiology at the Harvard School of Public Health (HSPH) and at the Harvard Medical School. He is the Deputy-Chairman and former Acting Chair of the Department of Epidemiology at the HSPH with responsibilities for the teaching matters of that department. In the past six years he has taught or directed 40 offerings of 9 different courses at HSPH. He developed and directs the Summer-Only Masters of Science (SM) in Epidemiology and the Summer-Only Masters of Public Health (MPH) (Clinical Effectiveness) Degree Programs at HSPH. He also directs the Concentration in Clinical Effectiveness within the MPH Program, which is the largest of the MPH Concentrations. He is the academic advisor for approximately 190 students at HSPH. Dr. Cook is a Co-Director of the seven-week Summer Program in Clinical Effectiveness at HSPH, which each summer trains over 250 clinicians from the Harvard Hospitals and from other national and international sites with the quantitative skills that are needed for clinical research. He also helped develop and is a Co-Director for the Programa de Efectividad Clinica in Buenos Aires. He is a member of the Scientific Advisory Board for the Center for Native Hawaiian and Pacific Islanders Heath Disparities Research at the University of Hawaii. He has won Citations for Excellence in Teaching from the Harvard School of Public Health on four occasions, the Alumni Award of Merit from the Harvard School of Public Health for his teaching and mentoring, the Teaching Award from the Center of Clinical Investigation at the Brigham and Women’s Hospital, and is a member the American Schools of Public Health/Pfizer Public Health Academy of Distinguished Teachers.
Heather J. Baer, ScD, is an Assistant Professor of Medicine and Epidemiology. Dr. Baer’s research focuses on the role of lifestyle factors in the etiology and prevention of chronic disease. She has conducted analyses within the Nurses’ Health Studies to examine how factors such as obesity, diet, and physical activity affect risk of cancer and overall mortality, and she is currently leading several projects to improve the assessment and management of obesity and other modifiable risk factors in primary care.
In addition to her research, Dr. Baer is actively involved in a number of teaching activities. She plays a major role in the Program in Clinical Effectiveness, an intensive, seven-week summer program that trains physicians in the quantitative skills for conducting clinical research. She is an Associate Director for Introduction to Clinical Epidemiology (EPI208) and also teaches in several other courses, including Introductory Statistics for Medical Research (BIO206) and Analytical Aspects of Clinical Epidemiology (EPI236). She also serves as a co-Director of the Summer MPH Practicum in Clinical Effectiveness (ID320) and the MPH Seminar in Applied Research in Clinical Epidemiology (EPI242) during the academic year. As part of her role in these courses, Dr. Baer advises fellows and junior faculty members on research projects for the completion of their MPH in Clinical Effectiveness. She also has served as a Tutorial Leader for Clinical Epidemiology and Population Health at Harvard Medical School (AC511.0), which is taken by all first-year medical and dental students.
E. John Orav, PhD is an Associate Professor of Biostatistics at Harvard Medical School and also at the Harvard School of Public Health. He received his PhD in Statistics from Stanford University and has worked as a collaborative biostatistician in the Division of General Medicine for the past 25 years. Dr. Orav is a Co-Director of the Summer Program in Clinical Effectiveness and teaches the introductory biostatistics courses for that program as well as a follow-up course in regression at the Harvard School of Public Health.
Dr. Orav is involved with a number of collaborative research projects ranging from clinical trials of medical and behavioral therapy for arthritis patients, to epidemiological studies of problem drinking and substance use, to a randomized trial of computerized risk score alerts for patients with chest pain. Much of his current research is involved with the use of hierarchical models for quality assessment and quality improvement, particularly through application of health information technology.
Dr. Orav has been involved with the quantitative training of academic physicians since the inception of the Program in Clinical Effectiveness 25 years ago. He designed the original biostatistics curriculum for that program and continues to teach both the introductory and advanced components each summer. Many of the continuing students also take the follow-up regression course that Dr. Orav designed and teaches every Fall. Through his dedicated teaching at the Harvard School of Public Health, Dr. Orav has earned two Nichols Teaching Awards, 2 Excellence in Teaching Citations, 2 Center for Clinical Investigation Excellence in Teaching Awards, and 1 Excellence in Teaching Award from the Harvard Medical School Clinical Scholars Program. In addition to helping to develop and evaluate the curriculum as a Co-Director of the Program in Clinical Effectiveness Program at Harvard, Dr. Orav has participated in clinical effectiveness programs in Argentina, Japan, and, for the past 4 years, in Russia.
Daniel E. Singer, MD, is Professor of Medicine at Harvard Medical School and also Professor in the Department of Epidemiology at the Harvard School of Public Health. He is Chief of the Clinical Epidemiology Unit and Associate Chief for Research in the General Medicine Division at Massachusetts General Hospital (MGH) and Director of the MGH General Medicine Research Fellowship.
Dr Singer is widely recognized for his research contributions in clinical epidemiology and preventive medicine, in particular the prevention of stroke in atrial fibrillation (AF). Dr. Singer received the 2003 John Eisenberg Award from the National Society for General Internal Medicine for Career Achievements in Research, and the 2008 C. Miller Fisher Award from the Massachusetts chapter of the American Stroke Association/American Heart Association for his contributions to stroke research.
Dr. Singer is an active teacher of clinical epidemiology research methods. He developed the clinical epidemiology curriculum for the New Pathway Project at Harvard Medical School in the 1980s. He then directed the core Introduction to Clinical Epidemiology course in the Harvard School of Public Health intensive summer 7-week Program in Clinical Effectiveness (PCE) for 12 years ending in 2006, and he continues to serve as a Co-Director of the course and as an Associate Director of PCE. Dr. Singer also directs Epi 242, the Seminar in Clinical Epidemiology, during the academic year. Epi 242 is the research presentation forum for students pursuing an MPH degree with a concentration in Clinical Effectiveness. Epi 208 and Epi 242 have consistently garnered recognition for excellent student evaluations. Dr. Singer has served as visiting faculty in clinical effectiveness programs in Japan and, for the past four years, in Russia, linking with PCE graduates in both countries.